131 related articles for article (PubMed ID: 25957595)
1. Circulating tumor cell clusters-associated gene plakoglobin and breast cancer survival.
Lu L; Zeng H; Gu X; Ma W
Breast Cancer Res Treat; 2015 Jun; 151(3):491-500. PubMed ID: 25957595
[TBL] [Abstract][Full Text] [Related]
2. Beyond cell-cell adhesion: Plakoglobin and the regulation of tumorigenesis and metastasis.
Aktary Z; Alaee M; Pasdar M
Oncotarget; 2017 May; 8(19):32270-32291. PubMed ID: 28416759
[TBL] [Abstract][Full Text] [Related]
3. Loss of plakoglobin promotes decreased cell-cell contact, increased invasion, and breast cancer cell dissemination in vivo.
Holen I; Whitworth J; Nutter F; Evans A; Brown HK; Lefley DV; Barbaric I; Jones M; Ottewell PD
Breast Cancer Res; 2012 May; 14(3):R86. PubMed ID: 22632416
[TBL] [Abstract][Full Text] [Related]
4. High motility of triple-negative breast cancer cells is due to repression of plakoglobin gene by metastasis modulator protein SLUG.
Bailey CK; Mittal MK; Misra S; Chaudhuri G
J Biol Chem; 2012 Jun; 287(23):19472-86. PubMed ID: 22496452
[TBL] [Abstract][Full Text] [Related]
5. In Vivo Detection of CTC and CTC Plakoglobin Status Helps Predict Prognosis in Patients with Metastatic Breast Cancer.
Xie N; Hu Z; Tian C; Xiao H; Liu L; Yang X; Li J; Wu H; Lu J; Gao J; Hu X; Cao M; Shui Z; Ouyang Q
Pathol Oncol Res; 2020 Oct; 26(4):2435-2442. PubMed ID: 32557169
[TBL] [Abstract][Full Text] [Related]
6. KRT13 promotes stemness and drives metastasis in breast cancer through a plakoglobin/c-Myc signaling pathway.
Yin L; Li Q; Mrdenovic S; Chu GC; Wu BJ; Bu H; Duan P; Kim J; You S; Lewis MS; Liang G; Wang R; Zhau HE; Chung LWK
Breast Cancer Res; 2022 Jan; 24(1):7. PubMed ID: 35078507
[TBL] [Abstract][Full Text] [Related]
7. Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells.
Joosse SA; Hannemann J; Spötter J; Bauche A; Andreas A; Müller V; Pantel K
Clin Cancer Res; 2012 Feb; 18(4):993-1003. PubMed ID: 22228641
[TBL] [Abstract][Full Text] [Related]
8. Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis.
Aceto N; Bardia A; Miyamoto DT; Donaldson MC; Wittner BS; Spencer JA; Yu M; Pely A; Engstrom A; Zhu H; Brannigan BW; Kapur R; Stott SL; Shioda T; Ramaswamy S; Ting DT; Lin CP; Toner M; Haber DA; Maheswaran S
Cell; 2014 Aug; 158(5):1110-1122. PubMed ID: 25171411
[TBL] [Abstract][Full Text] [Related]
9. Plakoglobin interacts with and increases the protein levels of metastasis suppressor Nm23-H2 and regulates the expression of Nm23-H1.
Aktary Z; Chapman K; Lam L; Lo A; Ji C; Graham K; Cook L; Li L; Mackey JR; Pasdar M
Oncogene; 2010 Apr; 29(14):2118-29. PubMed ID: 20101217
[TBL] [Abstract][Full Text] [Related]
10. Biologic role of activated leukocyte cell adhesion molecule overexpression in breast cancer cell lines and clinical tumor tissue.
Hein S; Müller V; Köhler N; Wikman H; Krenkel S; Streichert T; Schweizer M; Riethdorf S; Assmann V; Ihnen M; Beck K; Issa R; Jänicke F; Pantel K; Milde-Langosch K
Breast Cancer Res Treat; 2011 Sep; 129(2):347-60. PubMed ID: 20972617
[TBL] [Abstract][Full Text] [Related]
11. Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer.
Goto W; Kashiwagi S; Asano Y; Takada K; Takahashi K; Hatano T; Takashima T; Tomita S; Motomura H; Ohsawa M; Hirakawa K; Ohira M
Biomark Res; 2017; 5():19. PubMed ID: 28507762
[TBL] [Abstract][Full Text] [Related]
12. Hormone receptor-independent CXCL10 production is associated with the regulation of cellular factors linked to breast cancer progression and metastasis.
Ejaeidi AA; Craft BS; Puneky LV; Lewis RE; Cruse JM
Exp Mol Pathol; 2015 Aug; 99(1):163-72. PubMed ID: 26079660
[TBL] [Abstract][Full Text] [Related]
13. DNMT3A and DNMT3B mediate autocrine hGH repression of plakoglobin gene transcription and consequent phenotypic conversion of mammary carcinoma cells.
Shafiei F; Rahnama F; Pawella L; Mitchell MD; Gluckman PD; Lobie PE
Oncogene; 2008 Apr; 27(18):2602-12. PubMed ID: 17998942
[TBL] [Abstract][Full Text] [Related]
14. Down-regulation of plakoglobin in soft tissue sarcoma is associated with a higher risk of pulmonary metastasis.
Kanazawa Y; Ueda Y; Shimasaki M; Katsuda S; Yamamoto N; Tomita K; Tsuchiya H
Anticancer Res; 2008; 28(2A):655-64. PubMed ID: 18507004
[TBL] [Abstract][Full Text] [Related]
15. Gene expression profiles of circulating tumor cells versus primary tumors in metastatic breast cancer.
Onstenk W; Sieuwerts AM; Weekhout M; Mostert B; Reijm EA; van Deurzen CH; Bolt-de Vries JB; Peeters DJ; Hamberg P; Seynaeve C; Jager A; de Jongh FE; Smid M; Dirix LY; Kehrer DF; van Galen A; Ramirez-Moreno R; Kraan J; Van M; Gratama JW; Martens JW; Foekens JA; Sleijfer S
Cancer Lett; 2015 Jun; 362(1):36-44. PubMed ID: 25797316
[TBL] [Abstract][Full Text] [Related]
16. Triggering of Toll-like receptor 4 on metastatic breast cancer cells promotes αvβ3-mediated adhesion and invasive migration.
Liao SJ; Zhou YH; Yuan Y; Li D; Wu FH; Wang Q; Zhu JH; Yan B; Wei JJ; Zhang GM; Feng ZH
Breast Cancer Res Treat; 2012 Jun; 133(3):853-63. PubMed ID: 22042369
[TBL] [Abstract][Full Text] [Related]
17. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
18. Plakoglobin interacts with the transcription factor p53 and regulates the expression of 14-3-3σ.
Aktary Z; Kulak S; Mackey J; Jahroudi N; Pasdar M
J Cell Sci; 2013 Jul; 126(Pt 14):3031-42. PubMed ID: 23687381
[TBL] [Abstract][Full Text] [Related]
19. Detection of circulating tumor cells in breast cancer may improve through enrichment with anti-CD146.
Mostert B; Kraan J; Bolt-de Vries J; van der Spoel P; Sieuwerts AM; Schutte M; Timmermans AM; Foekens R; Martens JW; Gratama JW; Foekens JA; Sleijfer S
Breast Cancer Res Treat; 2011 May; 127(1):33-41. PubMed ID: 20379845
[TBL] [Abstract][Full Text] [Related]
20. Comparative analysis of innate immune system function in metastatic breast, colorectal, and prostate cancer patients with circulating tumor cells.
Santos MF; Mannam VK; Craft BS; Puneky LV; Sheehan NT; Lewis RE; Cruse JM
Exp Mol Pathol; 2014 Jun; 96(3):367-74. PubMed ID: 24731923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
